PATENT CLAIM ANALYSIS

Application Number: 15864994
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "245000"]

Abstract:
Provided are compounds useful for treating cancer and methods of treating cancer, for example an advanced solid tumor, such as a glioma, or angioimmunoblastic T-cell lymphoma (AITL).

Claim (Index 32):
The method of  claim 31 , wherein the therapeutically effective dose is about 30 mg, or about 50 mg, or about 75 mg, or about 100 mg, or about 125 mg, or about 150 mg, or about 175 mg, or about 200 mg, or about 225 mg, or about 250 mg or about 275 mg, or about 300 mg.

Metadata:
- Claim Count in Document: 70.0
- Percentile: 86.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14909451', '15649551', '15612984', '14868283', '15548737']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8505793969716041
- 35 USC 102 Novelty (BERT): 0.5920560628450445
- Combined Prediction Score: 0.8247270635589482
- Mean Citation Score: 489.79634
- Max Citation Score: 507.67773
- Similarity Product: 454.3158198375213

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test